|
GE Healthcare, IntrinsiQ to focus on oncology EMR
|
06/01/07 CHICAGO – GE Healthcare and IntrinsiQ, a provider of cancer care
software, are teaming up to provide clinical information within the
patient’s electronic medical record.
Waltham, MA-based IntrinsiQ developed IntelliDose, software that automates the process of chemotherapy order entry.
The technology is designed to minimize the potential for error by
producing legible, complete and electronically checked orders.
Studies have shown that chemotherapy errors can be
traced to a variety of issues related to human error, procedural flaws
and lack of standardization, the two companies said in a news release.
IntrinsiQ plans to interface these capabilities with GE’s Centricity electronic medical record system.
The electronic record will hold data about chemotherapy, including drug administration records and nurse notes.
“Merging yet another key piece of patient data within
our Centricity EMR solution demonstrates our commitment to providing
comprehensive clinical information systems for our providers and their
patients,” said Stephen Gorman, vice president and general manager for
GE Healthcare Integrated IT Solutions,
“Previously chemotherapy treatment was calculated and documented using
pen and paper,” said Simeon Schwartz, MD, chief executive officer of
Westchester Medical Group. “Not only was this extremely inefficient but
more importantly it could lead to potential human error. By
interfacing our Centricity EMR system with the Intellidose software,
our practice has virtually gone from the Flintstones to the Jetsons in
a matter of weeks.”
GE Healthcare and IntrinsiQ announced their partnership this week at
the 43rd annual meeting of the American Society of Clinical Oncology in
Chicago.
Source:
Healthcare IT News
|
|
|